Skip to Content
Merck

201014

N-Benzylbenzamide

≥98%

Synonym(s):

Benzoic acid benzylamide, N-(Phenylmethyl)benzamide, N-Benzoylbenzylamine

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
C6H5CONHCH2C6H5
CAS Number:
Molecular Weight:
211.26
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
216-063-4
MDL number:
Assay:
≥98%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥98%

mp

104-106 °C (lit.)

solubility

acetone: 25 mg/mL, clear, colorless

functional group

amide, phenyl

SMILES string

O=C(NCc1ccccc1)c2ccccc2

InChI

1S/C14H13NO/c16-14(13-9-5-2-6-10-13)15-11-12-7-3-1-4-8-12/h1-10H,11H2,(H,15,16)

InChI key

LKQUCICFTHBFAL-UHFFFAOYSA-N

General description

N-Benzylbenzamide inhibits the activity of tyrosinase.

Application

A convenient precursor to α-substituted benzylamines and an indicator for the titration of butyllithium and other lithium bases. For references see Aldrichimica Acta .


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Yae Eun Chong et al.
Biomedical chromatography : BMC, 33(11), e4653-e4653 (2019-07-20)
Ondansetron, a widely used antiemetic agent, is a P-glycoprotein (P-gp) substrate and therefore expression of P-gp at the blood-brain barrier limits its distribution to the central nervous system (CNS), which was observed to be reversed by coadministration with P-gp inhibitors.
Manting Chiang et al.
Pharmaceutical research, 37(10), 205-205 (2020-09-30)
Modulation of 5-HT3 receptor in the central nervous system (CNS) is a promising approach for treatment of neuropathic pain. The goal was to evaluate the role of P-glycoprotein (Pgp) in limiting exposure of different parts of the CNS to ondansetron
Sung Jin Cho et al.
Bioorganic & medicinal chemistry letters, 16(10), 2682-2684 (2006-03-04)
A series of potent inhibitors of tyrosinase and their structure-activity relationships are described. N-Benzylbenzamide derivatives (1-21) with hydroxyl(s) were synthesized and tested for their tyrosinase inhibitory activity. With this series, compound 15 provided a potent tyrosinase inhibition: it effectively inhibited



Global Trade Item Number

SKUGTIN
201014-5G04061831828825